The company maintains a strained capital structure with a current ratio consistently below 1.0 and a debt-to-equity ratio that reached a peak of 22.52 in 2025Q1, reflecting high sensitivity to leverage.
| Metric | TTM | Sep'25 | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Sep'09 | Sep'08 | Sep'07 | Sep'06 | Sep'05 | Sep'04 | Sep'03 | Sep'02 | Sep'01 | Sep'00 | Sep'99 | Sep'98 | Sep'97 | Sep'96 |
|---|
| Total Current Assets | 53.14B | 52.24B | 47.72B | 42.8B | 39.59B | 38.8B | 33.02B | 28.13B | 25.89B | 24.3B | 22.79B | 20.33B | 16.8B | 14.39B | 10.99B | 11.22B | 10.75B | 9.95B | 8.67B | 8.71B | 9.21B | 7.99B | 8.3B | 8.86B | 8.35B | 7.51B | 2.32B | 1.92B | 1.42B | 1.62B | 1.12B |
| Cash & Short-Term Investments | 2.24B | 4.39B | 3.23B | 2.69B | 3.53B | 2.55B | 4.6B | 3.37B | 2.49B | 2.44B | 2.77B | 2.22B | 1.81B | 1.23B | 1.07B | 1.83B | 1.66B | 1.01B | 878.11M | 1.11B | 1.33B | 1.32B | 871.34M | 800.04M | 663.34M | 297.63M | 120.82M | 59.5M | 48.5M | 60M | 65.6M |
| Cash Only | 2.24B | 4.39B | 3.23B | 2.69B | 3.53B | 2.55B | 4.6B | 3.37B | 2.49B | 2.44B | 2.74B | 2.17B | 1.81B | 1.23B | 1.07B | 1.83B | 1.66B | 1.01B | 878.11M | 640.2M | 1.26B | 966.55M | 871.34M | 800.04M | 663.34M | 297.63M | 120.82M | 59.5M | 48.5M | 60M | 65.6M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.1M | 50.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 467.42M | 67.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 24.89B | 25.23B | 23.87B | 20.91B | 18.63B | 18.39B | 14.3B | 12.39B | 11.31B | 10.3B | 9.18B | 8.22B | 6.31B | 6.05B | 3.94B | 3.84B | 3.83B | 3.92B | 3.48B | 3.47B | 3.43B | 2.64B | 2.26B | 2.3B | 2.22B | 2.14B | 623.96M | 612.5M | 458.2M | 533.3M | 390.3M |
| Days Sales Outstanding | 27.95 | 28.65 | 29.64 | 29.11 | 28.49 | 31.37 | 27.48 | 25.18 | 24.59 | 24.56 | 22.81 | 22.08 | 19.27 | 25.11 | 18.09 | 17.46 | 17.92 | 19.92 | 18.1 | 19.18 | 20.44 | 17.66 | 15.52 | 16.87 | 17.93 | 48.3 | 19.56 | 22.8 | 19.29 | 24.9 | 25.66 |
| Inventory | 20.01B | 20.49B | 19B | 17.45B | 17.09B | 15.37B | 12.59B | 11.06B | 11.92B | 11.46B | 10.72B | 9.76B | 8.59B | 6.98B | 5.69B | 5.47B | 5.21B | 4.97B | 4.21B | 4.1B | 4.42B | 4B | 5.14B | 5.73B | 5.44B | 5.06B | 1.57B | 1.24B | 870.2M | 1.02B | 650.3M |
| Days Inventory Outstanding | 24.39 | 24.04 | 24.31 | 25.04 | 27 | 27 | 24.82 | 23.06 | 26.55 | 28.08 | 27.36 | 26.82 | 26.86 | 29.76 | 26.98 | 25.65 | 25.12 | 26.03 | 22.53 | 23.44 | 27.31 | 27.72 | 36.71 | 44.14 | 45.93 | 119.13 | 51.53 | 48.63 | 38.52 | 50.02 | 45.24 |
| Other Current Assets | 6B | 2.13B | 1.71B | 1.84B | 342.89M | 2.13B | 1.53B | 1.31B | 169.12M | 118.56M | 148.32M | 189M | 84.96M | 129.23M | 73.81M | 87.9M | 52.59M | 55.06M | 43.69M | 32.82M | 32.1M | 27.67M | 27.24M | 29.21M | 26.26M | 15.96M | 5.34M | 4.8M | 41.4M | 13.6M | 8.9M |
| Total Non-Current Assets | 28.51B | 24.35B | 19.38B | 19.76B | 16.97B | 18.54B | 11.22B | 11.04B | 11.78B | 11.01B | 10.8B | 7.4B | 4.73B | 4.52B | 4.46B | 3.77B | 3.69B | 3.62B | 3.55B | 3.6B | 3.57B | 3.39B | 3.36B | 3.18B | 2.86B | 2.78B | 137.95M | 140.6M | 134M | 120.3M | 72.9M |
| Property, Plant & Equipment | 2.81B | 4.09B | 3.32B | 3.15B | 3.08B | 3.23B | 1.93B | 1.77B | 1.89B | 1.8B | 1.53B | 1.19B | 899.58M | 803.56M | 780.01M | 772.92M | 711.71M | 619.24M | 552.16M | 506.98M | 509.75M | 514.76M | 465.26M | 353.17M | 282.58M | 289.57M | 64.96M | 64.4M | 60.8M | 67.5M | 51.7M |
| Fixed Asset Turnover | 111.65x | 78.61x | 88.46x | 83.11x | 77.46x | 66.25x | 98.48x | 101.43x | 88.74x | 85.18x | 95.94x | 114.01x | 132.92x | 109.46x | 101.91x | 103.79x | 109.53x | 115.88x | 127.12x | 130.33x | 120.07x | 106.03x | 114.30x | 140.60x | 160.08x | 55.92x | 179.26x | 152.29x | 142.58x | 115.79x | 107.38x |
| Goodwill | 16.45B | 13.68B | 9.32B | 9.57B | 8.5B | 9.03B | 6.71B | 6.71B | 6.66B | 6.04B | 5.99B | 4.13B | 2.95B | 2.94B | 2.97B | 2.57B | 2.54B | 2.54B | 2.88B | 2.61B | 2.59B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 6.05B | 3.77B | 4B | 4.43B | 4.33B | 5.26B | 1.89B | 2.29B | 2.95B | 2.83B | 2.97B | 1.99B | 533.24M | 554.74M | 580.45M | 297.86M | 300.98M | 316.71M | 0 | 477.73M | 475.06M | 2.88B | 2.89B | 2.83B | 2.57B | 2.47B | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 66.64M | 63.12M | 60.37M | 0 | 0 | -1.86B | 0 | 57.6M | 56.7M | 30.5M | 117.8M | -1B | -963.08M | 0 | 0 | 1.94B | -550.71M | -1.91B | 0 | 2.83B | 1.44B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.01B | 2.6B | 2.43B | 2.34B | 756.32M | 726.81M | 336.33M | 269.07M | 270.94M | 280.06M | 238.93M | 267.97M | 232.85M | 221.71M | 123.42M | 129.05M | 129.44M | 140.68M | 120.5M | 135.55M | 139.88M | 146.06M | 124.27M | 0 | 0 | 0 | 72.99M | 76.2M | 73.2M | 52.8M | 21.2M |
| Total Assets | 81.65B | 76.59B | 67.1B | 62.56B | 56.56B | 57.34B | 44.27B | 39.17B | 37.67B | 35.32B | 33.59B | 27.74B | 21.53B | 18.92B | 15.44B | 14.98B | 14.43B | 13.57B | 12.22B | 12.31B | 12.78B | 11.38B | 11.65B | 12.04B | 11.21B | 10.29B | 2.46B | 2.06B | 1.55B | 1.75B | 1.19B |
| Asset Turnover | 4.23x | 4.20x | 4.38x | 4.19x | 4.22x | 3.73x | 4.29x | 4.58x | 4.46x | 4.34x | 4.37x | 4.90x | 5.55x | 4.65x | 5.15x | 5.35x | 5.40x | 5.29x | 5.74x | 5.37x | 4.79x | 4.80x | 4.56x | 4.12x | 4.03x | 1.57x | 4.74x | 4.76x | 5.58x | 4.48x | 4.67x |
| Asset Growth % | 53.07% | 14.14% | 7.26% | 10.6% | -1.36% | 29.5% | 13.03% | 3.99% | 6.66% | 5.14% | 21.1% | 28.81% | 13.81% | 22.5% | 3.08% | 3.8% | 6.35% | 11.09% | -0.75% | -3.71% | 12.33% | -2.34% | -3.21% | 7.38% | 8.96% | 318.59% | 19.31% | 32.75% | -11.04% | 46.89% | 41.65% |
| Total Current Liabilities | 56.13B | 57.82B | 54.28B | 48.83B | 43.48B | 41.36B | 33.85B | 29.58B | 27.87B | 26.77B | 25.24B | 22.7B | 17.25B | 14.87B | 11.21B | 10.86B | 9.91B | 9.48B | 8.17B | 7.86B | 7.46B | 6.05B | 6.1B | 6.26B | 6.1B | 5.53B | 1.75B | 1.33B | 1.02B | 1.13B | 785.8M |
| Accounts Payable | 51.88B | 54.72B | 50.94B | 45.84B | 40.19B | 38.01B | 31.71B | 28.39B | 26.84B | 25.4B | 23.93B | 20.89B | 15.59B | 13.34B | 9.63B | 9.2B | 8.83B | 8.52B | 7.33B | 6.99B | 6.5B | 5.29B | 4.95B | 5.39B | 5.37B | 4.99B | 1.58B | 1.18B | 873.2M | 1.04B | 715M |
| Days Payables Outstanding | 61.51 | 64.18 | 65.18 | 65.76 | 63.51 | 66.79 | 62.52 | 59.18 | 59.79 | 62.23 | 61.04 | 57.43 | 48.73 | 56.84 | 45.66 | 43.18 | 42.59 | 44.58 | 39.19 | 39.94 | 40.14 | 36.64 | 35.36 | 41.53 | 45.34 | 117.62 | 51.98 | 45.98 | 38.65 | 50.94 | 49.74 |
| Short-Term Debt | 202.66M | 371.56M | 781.1M | 823.81M | 1.23B | 475.56M | 593.85M | 139.01M | 151.66M | 12.12M | 610.21M | 0 | 0 | 0 | 0 | 392.09M | 422K | 1.07M | 1.72M | 476K | 1.56M | 1.23M | 281.36M | 61.43M | 60.82M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 753.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.05B | 2.73B | 2.55B | 2.17B | 2.06B | 2.87B | 1.55B | 1.06B | 881.16M | 1.4B | 743.84M | -443.23M | 561.86M | 532.56M | 621.29M | 422.92M | 369.02M | 315.66M | 288.58M | 338.56M | 403.91M | 335.65M | 419.38M | 47.8M | 670.86M | 540.57M | 167.34M | 151.7M | 142M | 93.6M | 70.8M |
| Current Ratio | 0.95x | 0.90x | 0.88x | 0.88x | 0.91x | 0.94x | 0.98x | 0.95x | 0.93x | 0.91x | 0.90x | 0.90x | 0.97x | 0.97x | 0.98x | 1.03x | 1.08x | 1.05x | 1.06x | 1.11x | 1.23x | 1.32x | 1.36x | 1.42x | 1.37x | 1.36x | 1.32x | 1.45x | 1.40x | 1.44x | 1.42x |
| Quick Ratio | 0.59x | 0.55x | 0.53x | 0.52x | 0.52x | 0.57x | 0.60x | 0.58x | 0.50x | 0.48x | 0.48x | 0.47x | 0.48x | 0.50x | 0.47x | 0.53x | 0.56x | 0.53x | 0.55x | 0.59x | 0.64x | 0.66x | 0.52x | 0.50x | 0.48x | 0.44x | 0.43x | 0.51x | 0.54x | 0.54x | 0.59x |
| Cash Conversion Cycle | -9.18 | -11.49 | -11.23 | -11.6 | -8.02 | -8.42 | -10.21 | -10.95 | -8.65 | -9.6 | -10.87 | -8.53 | -2.6 | -1.97 | -0.6 | -0.07 | 0.45 | 1.37 | 1.44 | 2.68 | 7.61 | 8.74 | 16.87 | 19.49 | 18.52 | 49.82 | 19.11 | 25.44 | 19.16 | 23.99 | 21.16 |
| Total Non-Current Liabilities | 21.93B | 17.02B | 12.04B | 13.06B | 13.01B | 15.39B | 11.26B | 6.89B | 7.1B | 6.43B | 6.23B | 5.77B | 2.33B | 1.73B | 1.77B | 1.26B | 1.57B | 1.38B | 1.34B | 1.35B | 1.18B | 1.05B | 1.21B | 1.78B | 1.8B | 1.92B | 424.8M | 567M | 461.8M | 600.6M | 439M |
| Long-Term Debt | 12.18B | 8.96B | 4.84B | 5.07B | 5.5B | 7.33B | 4B | 4.03B | 4.16B | 3.43B | 3.58B | 3.49B | 2B | 1.4B | 1.45B | 972.86M | 1.34B | 1.18B | 1.19B | 1.23B | 1.09B | 951.48M | 1.16B | 1.72B | 1.76B | 1.6B | 413.22M | 558.7M | 453.8M | 589.8M | 433.7M |
| Capital Lease Obligations | 1.42B | 1.42B | 1.03B | 924.25M | 864.29M | 946.15M | 385.51M | 0 | 0 | 351.63M | 275.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 6.62B | 1.62B | 1.64B | 1.66B | 1.62B | 1.69B | 686.49M | 1.86B | 1.83B | 2.49B | 2.21B | 819.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8B | 5.03B | 4.52B | 5.41B | 5.03B | 5.43B | 6.19B | 382.89M | 409.95M | 159.66M | 160.47M | 84.9M | 329.49M | 331.65M | 326.16M | 287.83M | 231.04M | 199.73M | 152.74M | 126.01M | 89.64M | 97.24M | 53.94M | 55.98M | 40.66M | 322.93M | 11.59M | 8.3M | 8M | 10.8M | 5.3M |
| Total Liabilities | 78.07B | 74.84B | 66.31B | 61.89B | 56.49B | 56.75B | 45.11B | 36.47B | 34.97B | 33.25B | 31.51B | 27.35B | 19.58B | 16.6B | 12.99B | 12.12B | 11.48B | 10.86B | 9.51B | 9.21B | 8.64B | 7.1B | 7.31B | 8.03B | 7.9B | 7.45B | 2.18B | 1.89B | 1.48B | 1.73B | 1.22B |
| Total Debt | 12.39B | 10.75B | 6.65B | 6.82B | 7.59B | 8.75B | 4.98B | 4.49B | 4.66B | 3.79B | 4.46B | 3.74B | 2B | 1.4B | 1.45B | 1.36B | 1.34B | 1.18B | 1.19B | 1.23B | 1.1B | 952.71M | 1.44B | 1.78B | 1.82B | 1.6B | 413.22M | 558.7M | 453.8M | 589.8M | 433.7M |
| Net Debt | 10.15B | 6.35B | 3.42B | 4.13B | 4.06B | 6.2B | 385.38M | 1.12B | 2.17B | 1.36B | 1.72B | 1.57B | 187.12M | 165.6M | 380.16M | -461.04M | -314.6M | 168.63M | 311.02M | 587.57M | -165.78M | -13.84M | 567.13M | 984.12M | 1.15B | 1.3B | 292.4M | 499.2M | 405.3M | 529.8M | 368.1M |
| Debt / Equity | 3.45x | 6.15x | 8.46x | 10.23x | 106.49x | 14.98x | - | 1.50x | 1.53x | 1.79x | 2.10x | 5.90x | 1.02x | 0.60x | 0.59x | 0.48x | 0.45x | 0.43x | 0.44x | 0.40x | 0.26x | 0.22x | 0.33x | 0.45x | 0.55x | 0.56x | 1.46x | 3.36x | 6.03x | 41.24x | - |
| Debt / EBITDA | 2.46x | 2.28x | 1.60x | 1.99x | 2.20x | 2.75x | 2.05x | 1.91x | 2.17x | 1.55x | 2.16x | 2.40x | 1.45x | 1.21x | 1.01x | 1.01x | 1.13x | 1.19x | 1.30x | 1.39x | 1.33x | 1.33x | 1.50x | 1.85x | 2.32x | 5.62x | 1.90x | 2.88x | 2.70x | 4.40x | 3.96x |
| Net Debt / EBITDA | 2.02x | 1.35x | 0.82x | 1.21x | 1.18x | 1.95x | 0.16x | 0.48x | 1.01x | 0.56x | 0.83x | 1.01x | 0.14x | 0.14x | 0.27x | -0.34x | -0.26x | 0.17x | 0.34x | 0.66x | -0.20x | -0.02x | 0.59x | 1.02x | 1.47x | 4.57x | 1.34x | 2.58x | 2.41x | 3.96x | 3.36x |
| Interest Coverage | 3.73x | 6.38x | 9.06x | 8.84x | 10.41x | 13.17x | -32.39x | 5.95x | 7.21x | 7.16x | 10.64x | 3.40x | 9.67x | 11.99x | 12.96x | 15.33x | 14.74x | 13.98x | 11.14x | 11.37x | 60.42x | 9.19x | 7.84x | - | 5.06x | - | - | - | - | - | - |
| Total Equity | 3.58B | 1.75B | 786.74M | 666.29M | 71.27M | 584.41M | -839.64M | 2.99B | 3.05B | 2.11B | 2.13B | 633.52M | 1.96B | 2.32B | 2.46B | 2.87B | 2.95B | 2.72B | 2.71B | 3.1B | 4.14B | 4.28B | 4.34B | 4.01B | 3.32B | 2.84B | 282.29M | 166.3M | 75.3M | 14.3M | -36.8M |
| Equity Growth % | 913.46% | 122.07% | 18.08% | 834.84% | -87.8% | 169.6% | -128.05% | -1.86% | 44.24% | -0.7% | 236.12% | -67.63% | -15.64% | -5.58% | -14.31% | -2.96% | 8.76% | 0.24% | -12.57% | -25.15% | -3.25% | -1.35% | 8.33% | 20.78% | 16.83% | 905.53% | 69.75% | 120.85% | 426.57% | 138.86% | 72.88% |
| Book Value per Share | 18.35 | 8.95 | 3.93 | 3.26 | 0.34 | 2.80 | -4.10 | 14.13 | 13.84 | 9.54 | 9.42 | 2.91 | 8.31 | 9.86 | 9.56 | 10.32 | 10.28 | 8.97 | 8.34 | 8.25 | 9.98 | 9.93 | 9.21 | 8.64 | 7.39 | 11.30 | 1.36 | 0.80 | 0.37 | 0.07 | -0.20 |
| Total Shareholders' Equity | 3.4B | 1.51B | 645.94M | 522M | -211.56M | 223.35M | -1.02B | 2.88B | 2.93B | 2.06B | 2.13B | 616.39M | 1.96B | 2.32B | 2.46B | 2.87B | 2.95B | 2.72B | 2.71B | 3.1B | 4.14B | 4.28B | 4.34B | 4.01B | 3.32B | 2.84B | 282.29M | 166.3M | 75.3M | 14.3M | -36.8M |
| Common Stock | 2.98M | 2.97M | 2.96M | 2.95M | 2.93M | 2.91M | 2.88M | 2.85M | 2.84M | 2.81M | 2.78M | 2.75M | 2.71M | 2.68M | 2.63M | 4.96M | 4.9M | 4.83M | 2.41M | 2.38M | 2.35M | 1.16M | 1.13M | 1.12M | 1.07M | 1.03M | 588K | 600K | 0 | 0 | 0 |
| Retained Earnings | 8.49B | 6.53B | 5.42B | 4.32B | 2.98B | 1.67B | 518.34M | 4.24B | 3.72B | 2.4B | 2.3B | 1.18B | 1.57B | 1.51B | 1.27B | 4.06B | 3.47B | 2.92B | 2.48B | 2.29B | 2.05B | 1.6B | 1.35B | 892.85M | 462.62M | 128.18M | 4.38M | -94.6M | -163.4M | -213.9M | -259.4M |
| Treasury Stock | -10.44B | -10.33B | -9.82B | -8.25B | -7.02B | -6.47B | -6.51B | -6.1B | -5.43B | -4.76B | -4.4B | -4.15B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -961.31M | -901.38M | -989.12M | -1.4B | -1.83B | -445.44M | -108.83M | -111.97M | -79.25M | -95.85M | -114.31M | -136.33M | -52.05M | -35.48M | -30.79M | -50.87M | -42.54M | -46.1M | -16.49M | -5.25M | -15.3M | -24.81M | -13.58M | -14.22M | -5.94M | -336K | 0 | -200K | 0 | 0 | 0 |
| Minority Interest | 187.36M | 239.07M | 140.8M | 144.28M | 282.83M | 361.06M | 179.29M | 114.29M | 117.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High leverage and volatility
As reported in recent financial filings, Cencora's debt-to-equity ratio has experienced extreme fluctuations, peaking at 22.52 in 2025Q1 before moderating to 3.45 by 2026Q2, which highlights the company's heavy reliance on debt to manage the working capital requirements inherent in its low-margin pharmaceutical distribution business model.
The significant swings in leverage suggest that the company's capital structure is highly sensitive to the timing of inventory procurement and acquisition financing. Investors should monitor whether this reliance on debt creates refinancing risks, particularly if interest rate environments remain elevated and pressure the company's already narrow net margins.
Based on the provided balance sheet data, goodwill has expanded from $9.7 billion in 2024Q1 to $16.5 billion by 2026Q2, representing a substantial portion of the company's $81.7 billion in total assets and indicating a strategy heavily dependent on inorganic growth through large-scale acquisitions.
The rising goodwill balance warrants further investigation into the carrying value of these assets, as any impairment could significantly erode the company's thin equity base. This asset mix suggests that Cencora's competitive position is increasingly tied to the successful operational integration of acquired entities rather than purely organic expansion.
According to quarterly balance sheet data, Cencora has consistently maintained a current ratio below 1.0, ranging from 0.87 to 0.95 over the last ten quarters, which suggests a structural reliance on continuous cash inflows to meet short-term obligations in its high-volume, low-margin operating environment.
This liquidity profile indicates that the company operates with a very narrow margin for error regarding its working capital management. Any disruption in the timing of accounts receivable or inventory turnover could potentially strain the company's ability to cover its immediate liabilities without resorting to additional short-term financing.
As indicated by the company's financial statements, equity levels have remained remarkably low relative to total assets, with a notable trough of $226.6 million in 2025Q1, reflecting the impact of aggressive capital allocation and potential share repurchases on the company's overall book value.
The minimal equity cushion suggests that the company's balance sheet is highly sensitive to any negative earnings shocks or asset write-downs. This capital structure appears to prioritize returns on invested capital over maintaining a robust equity buffer, which may leave the company vulnerable during periods of industry-wide volatility.
Quick answers to the most common questions about buying COR stock.
As of 2025, Cencora, Inc. (COR) had total assets of $76.59B including $52.24B in current assets.
Cencora, Inc. (COR) carries total debt of $10.75B, offset by $4.39B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cencora, Inc. (COR) has total shareholders' equity (book value) of $1.51B ($8.95 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cencora, Inc. (COR) reported a current ratio of 0.90x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.